faes farma sa (FAE:Continuous)
faes farma sa (FAE) Snapshot
|
Open
€2.23
|
Previous Close
€2.21
|
|
|
Day High
€2.23
|
Day Low
€2.19
|
|
|
52 Week High
01/14/13 - €2.60
|
52 Week Low
07/17/12 - €1.11
|
|
|
Market Cap
476.0M
|
Average Volume 10 Days
216.6K
|
|
|
EPS TTM
€0.09
|
Shares Outstanding
217.3M
|
|
|
EX-Date
12/21/12
|
P/E TM
23.9x
|
|
|
Dividend
€0.04
|
Dividend Yield
1.76%
|
Related News
faes farma sa (FAE) Related Businessweek News
No Related Businessweek News Foundfaes farma sa (FAE) Details
FAES FARMA S.A. engages in the research, development, manufacture, commercialization, and marketing of pharmaceutical products and raw materials in Spain, Portugal, and internationally. It offers prescription, OTC, and skin-care treatment products. The company’s products include Bilastine, an antihistamine for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria in adults and children; F-97013-GD, an antipsychotic product, which is in pre-clinical phases; F-98214-TA, an antidepressant that is in pre-clinical phases; and Serotonin reuptake inhibitors. FAES FARMA S.A. was founded in 1933 and is based in Vizcaya, Spain.
faes farma sa (FAE) Key Developments
Faes Farma SA, 2012 Earnings Call, Mar 01, 2013
Faes Farma SA Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013 . Venue: Centre Covencions International Barcelona, Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain.
Faes Farma SA announced earnings results for the nine months ended September 2012. For the period, the company’s total revenue was €147,841,000 compared to €159,470,000 for the same period in 2011. EBIT was €20,347,000 compared to €16,198,000 for the same period in 2011. Profit before tax was €19,056,000 compared to €14,260,000 for the same period in 2011. Net profit was €19,315,000 compared to €14,533,000 for the same period in 2011.
| Recently Viewed | |||
| FAE:SM | €2.19 EUR | -0.015 |  |
| Company | Last | Change |
| Procter & Gamble Co/The | $80.02 USD | -0.18 |
| Recordati SpA | €7.97 EUR | -0.055 |
| Salix Pharmaceuticals Ltd | $59.28 USD | +0.09 |
| Shire PLC | 2,071 GBp | +21.00 |
| Warner Chilcott PLC | $19.21 USD | -0.07 |
| View Industry Companies | ||
Industry Analysis
FAE
Industry Average
| Valuation | FAE | Industry Range |
| Price/Earnings | -- | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | 2.4x |
|
| Price/Cash Flow | 16.4x |
|
| TEV/Sales | 2.3x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: Apr 29
Sponsored Financial Commentaries
Sponsored Links
To contact FAES FARMA SA, please visit www.faes.es. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
